Using blood markers to predict nerve invasion in pancreatic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the neutrophil-to-lymphocyte ratio and CA 19.9 levels as potential predictors of perineural invasion in patients with pancreatic cancer. By analyzing preoperative blood counts and CA 19.9 levels in patients diagnosed with adenocarcinoma who have undergone surgical resection, the study seeks to identify key prognostic factors that could influence clinical management. The focus is on understanding how these markers correlate with perineural invasion, which is a significant factor affecting patient prognosis. The findings could help in risk stratification and treatment planning for pancreatic cancer patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with a histopathological diagnosis of adenocarcinoma.
* Surgical resection of the neoplasm.
* Preoperative blood count allowing calculation of the neutrophil-to-lymphocyte ratio and preoperative CA 19.9, both before and after neoadjuvant therapy.

Exclusion Criteria:

* Patients with a diagnosis of another histological type.
* Patients with incomplete data.
* Patients who were not operated on.

Where it's running

• University Hospital of Gran Canaria Doctor Negrín
  Las Palmas de Gran Canaria, Las Palmas, Spain Recruiting

Study contacts

• Study coordinator: Pau Plá Sánchez
• Email: paups88@gmail.com
• Phone: 34 620541910

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• BEFAST: Total Body PET/CT with Ga-68 FAPI for Better Imaging in Cancer

  This study tests whether Ga-68 FAPI-46 Total Body PET/CT can better detect cancer spread and provide fast, clear images for adults with pancreatic or gastroesophageal cancer.

  Recruiting Phase 2 Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT07629609

• Chronic Stress and Pancreatic Cancer Outcomes in People with Pancreatic Cancer

  This study tests whether ongoing psychological stress affects how pancreatic cancer behaves and responds to treatment in adults.

  Recruiting Shanghai Zhongshan Hospital · Changsha, Hunan and 2 other locations · NCT07529626

• Prehab to get stronger before pancreatic cancer surgery

  This project will test whether adults with pancreatic cancer can follow a combined exercise, nutrition, and symptom-management program during chemotherapy to improve fitness and recovery before surgery.

  Recruiting University of Massachusetts, Worcester · Worester, Massachusetts · NCT07478185

• Surufatinib with Gemcitabine and Nab-paclitaxel as Neoadjuvant Therapy for High-Risk or Borderline Resectable Pancreatic Cancer

  This trial tests whether adding surufatinib to gemcitabine and nab-paclitaxel before surgery helps adults with high-risk resectable or borderline resectable pancreatic cancer.

  Recruiting Phase 3 Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07436741

• Peptamen 1.6 versus Resource HP/HC for nutrition after cephalic pancreaticoduodenectomy

  This tests whether Peptamen 1.6, a hydrolysed whey protein oral supplement, helps malnourished or at-risk adults recover better than a standard high-protein/high-calorie formula after cephalic pancreaticoduodenectomy for pancreatic or periampullary cancer.

  Recruiting Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Málaga, Málaga · NCT06852014

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.